TCT 2019 | FORZA: OCT vs FFR to Define Intermediate Lesions: Anatomy or Function?

Courtesy of SBHCI. 

Both fractional flow reserve (FFR) and optimal coherence tomography (OCT) can be useful to help define intermediate coronary lesions and optimize PCI outcomes.

Highlights TCT 2019

The FORZA study presented at San Francisco TCT 2019 scientific sessions simultaneously published in JACC randomized patients with intermediate lesions 1:1 to FFR vs OCT.

For the FFR arm, PCI was performed if FFR was ≤0.8; for the OCT arm, revascularization followed only if stenosis area was ≥75% or between 50 and 75%, with minimal luminal area <2.5 mm², or plaque rupture. 

Angina (by Seattle questionnaire) major cardiac events and cost were assessed by the end of the study. Primary end point was the classic composite of MACE plus significative angina (<90 SAQ frequency scale) at 13 months. 


Read also: TCT 2019 | PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk.


A total 350 patients with 446 intermediate lesions were randomized to FFR (n=176) or OCT (n=174).

Primary end point of MACE plus significative angina at 13 months occurred in 14.8% of patients receiving FFR vs 8% of patients receiving OCT (p=0.048). This outcome was driven by non-significant occurrence of all primary end point components. 

By the end of follow up, the need for antianginal medication was significantly higher in the FFR group (p<0.001) though the total cost was much lower (p<0.001) compared against OCT.

Conclusion

In patients with intermediate lesions by angiography, guiding revascularization with OCT was associated with lower end point rate (composite of MACE and significant angina). FFR required more medication to control the symptoms, but the final cost was much lower. 

Courtesy of SBHCI. 

Link to the SBHCI Publication HERE

forza-tct2019

forza-art-or

Original Title: FORZA: A Randomized Trial of Fractional Flow Reserve vs. Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses.

Author of the Original Article: Francesco Burzotta.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....